SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-22-000103
Filing Date
2022-01-14
Accepted
2022-01-14 16:47:05
Documents
90
Period of Report
2021-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q lxrp_10q.htm   iXBRL 10-Q 935367
2 EX-10.1 lxrp_ex101.htm EX-10.1 121907
3 EX-10.2 lxrp_ex102.htm EX-10.2 95730
4 EX-31.1 lxrp_ex311.htm EX-31.1 11584
5 EX-31.2 lxrp_ex312.htm EX-31.2 9310
6 EX-32.1 lxrp_ex321.htm EX-32.1 3951
7 EX-32.2 lxrp_ex322.htm EX-32.2 4346
13 lxrp_10qimg1.jpg GRAPHIC 1582
  Complete submission text file 0001640334-22-000103.txt   5206630

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA lexx-20211130.xsd EX-101.SCH 60144
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE lexx-20211130_lab.xml EX-101.LAB 280160
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lexx-20211130_cal.xml EX-101.CAL 25992
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lexx-20211130_pre.xml EX-101.PRE 245063
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lexx-20211130_def.xml EX-101.DEF 114362
84 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_10q_htm.xml XML 949105
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 001-39874 | Film No.: 22532381
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences